Published in PLoS One on December 02, 2014
Environmental Enteric Dysfunction is Associated with Carnitine Deficiency and Altered Fatty Acid Oxidation. EBioMedicine (2017) 0.81
Metabolic alterations in children with environmental enteric dysfunction. Sci Rep (2016) 0.78
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis. Gastroenterology (2015) 0.76
Metabolomics studies identify novel diagnostic and prognostic indicators in patients with alcoholic hepatitis. World J Hepatol (2016) 0.76
Metabonomic window into hepatitis B virus-related hepatic diseases. World J Hepatol (2016) 0.75
Plasma Amino Acid Profile in Patients with Aortic Dissection. Sci Rep (2017) 0.75
New treatment options for alcoholic hepatitis. World J Gastroenterol (2016) 0.75
Insulin resistance in clinical and experimental alcoholic liver disease. Ann N Y Acad Sci (2015) 0.75
Emerging concepts in alcoholic hepatitis. World J Hepatol (2017) 0.75
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology (2001) 8.09
Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J (1991) 5.30
Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology (2011) 5.06
Alcoholic hepatitis. N Engl J Med (2009) 4.98
Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol (2006) 3.59
Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr (2001) 3.54
Corticosteroid therapy of alcoholic hepatitis. Gastroenterology (1978) 3.21
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem (2002) 2.61
EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol (2012) 2.52
Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol (2009) 2.45
Excess weight risk factor for alcoholic liver disease. Hepatology (1997) 2.22
An application of Random Forests to a genome-wide association dataset: methodological considerations & new findings. BMC Genet (2010) 1.96
Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism (2010) 1.77
Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol (2011) 1.72
Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics (2011) 1.69
Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks. Bioinformatics (2010) 1.62
Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol (2004) 1.43
Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J (2014) 1.38
Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol (2012) 1.37
Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins. Alcohol (2004) 1.29
Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection. J Virol (2007) 1.29
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology (1996) 1.26
Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant (2008) 1.23
ALCOHOL: its metabolism and interaction with nutrients. Annu Rev Nutr (2000) 1.21
Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids. PLoS One (2013) 1.10
Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr Mol Med (2003) 1.09
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front Physiol (2012) 1.07
The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther (2010) 1.05
Alcoholic liver disease and malnutrition. Alcohol Clin Exp Res (2011) 0.93
A basis of the acanthocytosis in inherited and acquired disorders. Med Hypotheses (2004) 0.92
Effects of ethanol feeding on the activity and regulation of hepatic carnitine palmitoyltransferase I. Arch Biochem Biophys (1988) 0.87
Liver alcoholic cirrhosis and spur-cell (acanthocytic) anaemia. A study of erythrocyte ghost composition and fluidity. Scand J Gastroenterol (1995) 0.86
Is a liver biopsy necessary in alcoholic hepatitis? J Hepatol (2012) 0.86
Value of ethyl glucuronide in plasma as a biomarker for recent alcohol consumption in the emergency room. Alcohol Alcohol (2008) 0.84
Biomarker characteristics of alcohol use in the U.S. Army. J Addict Dis (2009) 0.78
The measurement of 1,2-propanediol, D, L-2,3-butanediol and meso-2,3-butanediol in controls and alcoholic cirrhotics. Alcohol Alcohol Suppl (1987) 0.77